{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:28:11Z","timestamp":1788460091318,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Union FEDER funds"},{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["FIS, PI12\/00523"],"award-info":[{"award-number":["FIS, PI12\/00523"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.trsl.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T12:28:17Z","timestamp":1438259297000},"page":"529-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antibodies to high-density lipoproteins are associated with inflammation and cardiovascular disease in rheumatoid arthritis patients"],"prefix":"10.1016","volume":"166","author":[{"given":"Javier","family":"Rodr\u00edguez-Carrio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Alperi-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Ballina-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Abal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2015.07.004_bib1","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rincon","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.07.004_bib2","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1136\/annrheumdis-2013-204933","article-title":"Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox","volume":"73","author":"Gonzalez-Gay","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2015.07.004_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/ard.2008.101964","article-title":"Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions","volume":"68","author":"Choy","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2015.07.004_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrrheum.2013.91","article-title":"Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm","volume":"9","author":"Robertson","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2015.07.004_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2015.07.004_bib6","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.ATV.0000094961.74697.54","article-title":"Endothelial protection by high-density lipoproteins: from bench to bedside","volume":"23","author":"Calabresi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.07.004_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.trsl.2015.07.004_bib8","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/art.34363","article-title":"Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.07.004_bib9","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/annrheumdis-2011-201148","article-title":"Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis","volume":"71","author":"Daien","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2015.07.004_bib10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3899\/jrheum.121358","article-title":"High-density lipoprotein profiling changes in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a cohort study","volume":"40","author":"Jamnitski","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2015.07.004_bib11","first-page":"446","article-title":"Increased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experience","volume":"27","author":"Schimmel","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.trsl.2015.07.004_bib12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/ard.2008.092171","article-title":"Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients","volume":"68","author":"Popa","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2015.07.004_bib13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1160\/TH12-10-0768","article-title":"Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases","volume":"109","author":"Carbone","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2015.07.004_bib14","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.10542","article-title":"Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"46","author":"Delgado","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.07.004_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.27286","article-title":"Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus","volume":"62","author":"O'Neill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.07.004_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/ken397","article-title":"Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus","volume":"48","author":"Batuca","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.trsl.2015.07.004_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2010.10.052","article-title":"TNFA-308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"216","author":"Rodriguez-Rodriguez","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2015.07.004_bib18","first-page":"705","article-title":"ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology","volume":"26","author":"van Gestel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2015.07.004_bib19","first-page":"367","article-title":"[Cardiovascular disease epidemiology and risk factors in primary care]","volume":"58","author":"Baena Diez","year":"2005","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.trsl.2015.07.004_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2015.07.004_bib21","first-page":"2440","article-title":"Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab","volume":"33","author":"Spanakis","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2015.07.004_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.semarthrit.2008.01.015","article-title":"Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment","volume":"38","author":"Steiner","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.07.004_bib23","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar1952","article-title":"Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment\u2013a prospective, controlled study","volume":"8","author":"Georgiadis","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.trsl.2015.07.004_bib24","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.07.004_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.2006.051672","article-title":"Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis","volume":"66","author":"van Halm","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2015.07.004_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJMoa1112072","article-title":"Tofacitinib or adalimumab versus placebo in rheumatoid arthritis","volume":"367","author":"van Vollenhoven","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.07.004_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/jre.12014","article-title":"Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis","volume":"48","author":"Wick","year":"2013","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.trsl.2015.07.004_bib28","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/annrheumdis-2012-201593","article-title":"Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study","volume":"72","author":"Chen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2015.07.004_bib29","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/annrheumdis-2011-200380","article-title":"Periodontal disease is significantly higher in non-smoking treatment-naive rheumatoid arthritis patients: results from a case-control study","volume":"71","author":"Potikuri","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2015.07.004_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/CS20070325","article-title":"Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome","volume":"115","author":"Vuilleumier","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.trsl.2015.07.004_bib31","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood.V97.8.2381","article-title":"Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes","volume":"97","author":"Hyka","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2015.07.004_bib32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11745-002-0981-4","article-title":"Apolipoproteins A-I and A-II downregulate neutrophil functions","volume":"37","author":"Furlaneto","year":"2002","journal-title":"Lipids"},{"key":"10.1016\/j.trsl.2015.07.004_bib33","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1172\/JCI118276","article-title":"Activation of cultured vascular endothelial cells by antiphospholipid antibodies","volume":"96","author":"Simantov","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.07.004_bib34","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/art.27546","article-title":"Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis","volume":"62","author":"Vuilleumier","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.07.004_bib35","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.110.961714","article-title":"Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis","volume":"122","author":"Drechsler","year":"2010","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.trsl.2015.07.004_bib36","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1194\/jlr.R800086-JLR200","article-title":"Myeloperoxidase, modified lipoproteins, and atherogenesis","volume":"50","author":"Nicholls","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2015.07.004_bib37","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","article-title":"Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies","volume":"101","author":"Raschi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2015.07.004_bib38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2796.2012.02530.x","article-title":"Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2\/CD14 complex","volume":"272","author":"Pagano","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.trsl.2015.07.004_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2015.03.009","article-title":"Red cell distribution width is associated with endothelial progenitor cell depletion and vascular-related mediators in rheumatoid arthritis","volume":"240","author":"Rodriguez-Carrio","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2015.07.004_bib40","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.4049\/jimmunol.0902199","article-title":"A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs","volume":"184","author":"Denny","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2015.07.004_bib41","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.34504","article-title":"Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis","volume":"64","author":"Thacker","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.07.004_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/CS20140554","article-title":"Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine","volume":"128","author":"Rodriguez-Carrio","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.trsl.2015.07.004_bib43","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/acr.21631","article-title":"Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?","volume":"64","author":"Finckh","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"Suppl","key":"10.1016\/j.trsl.2015.07.004_bib44","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1194\/jlr.R800097-JLR200","article-title":"The HDL proteome: a marker\u2013and perhaps mediator\u2013of coronary artery disease","volume":"50","author":"Heinecke","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2015.07.004_bib45","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1021\/bi0518040","article-title":"Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK\/ERK and JNK signaling","volume":"45","author":"Beers","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.trsl.2015.07.004_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcb.24656","article-title":"Inhibition of apolipoprotein A-I expression by TNF-alpha in HepG2 cells: requirement for c-jun","volume":"115","author":"Parseghian","year":"2014","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.trsl.2015.07.004_bib47","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/annrheumdis-2012-202789","article-title":"Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic","volume":"72","author":"Rollefstad","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2015.07.004_bib48","first-page":"1459","article-title":"Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study","volume":"34","author":"Charles-Schoeman","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2015.07.004_bib49","first-page":"1495","article-title":"Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis","volume":"35","author":"Peters","year":"2008","journal-title":"J Rheumatol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524415002522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524415002522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T22:29:14Z","timestamp":1567031354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524415002522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1931524415002522"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2015.07.004","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies to high-density lipoproteins are associated with inflammation and cardiovascular disease in rheumatoid arthritis patients","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}